Use of Alternative Medicine in Patients With Dementia and Mild Cognitive Dysfunction
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01554475|
Recruitment Status : Completed
First Posted : March 15, 2012
Last Update Posted : February 18, 2015
|Condition or disease|
|Dementia Cognitive Impairment|
Patients: All patients with a diagnosis of dementia under follow-up at the out-patient clinic are invited to participate, if giving a written consent.
Method: a semi-structured interview is undertaken by the doctor at the end of the consultation. Patients and their company are asked to name their alternative medicines (if any), for how long the products have been used, where and how they learned about the products, ant to tell about their experiences with the products (i.e if they have noticed effects or side-effects). After the consultation information of the the actual product's contents and properties are obtained and an assessment of possible interactions with the patient's other drugs (prescriptions and self-reported use of over-the-counter drugs) is made. Reported effects or side-effects are registered.
|Study Type :||Observational|
|Actual Enrollment :||151 participants|
|Official Title:||Use of Alternative Medicine Among Patients With Dementia and Mild Cognitive Dysfunction|
|Study Start Date :||March 2012|
|Actual Primary Completion Date :||October 2014|
|Actual Study Completion Date :||October 2014|
- Number of patients taking alternative medicines [ Time Frame: Up to 2 years ]The patient's use of alternative medicine(s) on a given point of time (the consultation date) as reported by the patient or by the next of kin who is the patient's companion during the consultation. The results will be presented as the number of patients taking alternative medicines
- Numbers of potential and clinical relevant interactions [ Time Frame: Up to 2 years ]Assessment of the potential of interactions between the patient's alternative medicines and prescribed or over-the-counter drugs in use at the date of the consultation. The assessment will be based on data from litterature reports. Results will be presented as numbers of potential and clinical relevant interactions.
- The patient's subjective experiences with alternative medicines [ Time Frame: up to 2 years ]In the interview the patients will be asked to tell if they have experienced positive, negative, or no effects related to their use of alternative medicines. Results will be presented as number of patients.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01554475
|Bodø, Norway, N-8076|
|Study Chair:||Trude Giverhaug, PhD||University Hospital North-Norway|